These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14873565)

  • 21. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. III. AB-100 (NSC-37095).
    BROWN CL; BERGSAGEL DE; LEVIN WC
    Cancer Chemother Rep; 1962 Aug; 21():81-5. PubMed ID: 13873596
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. I. Plan of study.
    BERGSAGEL DE; SPRAGUE CC; ROSS SW
    Cancer Chemother Rep; 1962 Aug; 21():69-74. PubMed ID: 13867795
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of multiple myeloma with I-aminocyclopentanecarboxylic acid (NSC-1026).
    KRANT MJ; ISZARD DM; ABADI A; CAREY RW
    Cancer Chemother Rep; 1962 Sep; 22():59-64. PubMed ID: 14459328
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of M and B 938 in myelomatosis.
    WARD HW
    J Fac Radiol; 1958 Oct; 9(4):221-2. PubMed ID: 24544992
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of multiple myeloma.
    PLATZER RF
    N Y State J Med; 1954 Jan; 54(1):103-10. PubMed ID: 13119890
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. V. 1-Aminocyclopentanecarboxylic acid (NSC-1026).
    BERGSAGEL DE; ROSS SW; BAKER DT
    Cancer Chemother Rep; 1962 Aug; 21():101-6. PubMed ID: 13867792
    [No Abstract]   [Full Text] [Related]  

  • 27. [Kahler's disease improved by cortisone].
    COSTE F; DELBARRE F; URO
    Rev Rhum Mal Osteoartic; 1952 Apr; 19(4):348-50. PubMed ID: 14958340
    [No Abstract]   [Full Text] [Related]  

  • 28. Diamidines in myelomatosis.
    BICHEL J
    Acta radiol; 1952 Jan; 37(1):65-73. PubMed ID: 14902604
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. II. Mitomycin C (NSC-26980).
    BERGSAGEL DE; ROSS SW; DAVIS P
    Cancer Chemother Rep; 1962 Aug; 21():75-80. PubMed ID: 13867793
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case of successful treatment with sarcolysin of a patient with myeloma].
    BAISOGOLOV GD; DOSHCHENKO VN; CHIZH AS
    Probl Gematol Pereliv Krovi; 1961 Aug; 6():51-4. PubMed ID: 13864079
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of patients with plasmocytoma].
    SANDKUHLER S
    Medizinische; 1956 Nov; 24(45):1601-3. PubMed ID: 13377999
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806).
    BERGSAGEL DE; SPRAGUE CC; AUSTIN C; GRIFFITH KM
    Cancer Chemother Rep; 1962 Aug; 21():87-99. PubMed ID: 13867794
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparative study of optimal medical care with and without azaserine in multiple myeloma.
    HOLLAND JF
    Clin Pharmacol Ther; 1961; 2():22-8. PubMed ID: 13715278
    [No Abstract]   [Full Text] [Related]  

  • 34. [Massive doses of prednisone in the treatment of plasmocytoma].
    BAGUENA CANDELA R; FORTEZA BOVER G
    Med Esp; 1962 Feb; 47():126-9. PubMed ID: 13863951
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of multiple myeloma with radioactive iodine and radioactive iodinated serum albumin.
    KRISS JP; BIERMAN HR; THOMAS SF; NEWELL RR
    Radiology; 1955 Aug; 65(2):241-9. PubMed ID: 13245970
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase II trials of mitomycin C, AB-100, NSC-1026, L-sarcolysin, and meta-sarcolysin, in the treatment of multiple myeloma.
    BERGSAGEL DE
    Cancer Chemother Rep; 1962 Feb; 16():261-66. PubMed ID: 13867796
    [No Abstract]   [Full Text] [Related]  

  • 37. On the effect of corticotropin (ACTH) on myelomatosis with special reference to the bone marrow and the serum proteins.
    Effersøe P; Gormsen H; Harboe N; Nielsen SE; Videbaek AA
    Acta Med Scand; 1952 May; 143(1):63-82. PubMed ID: 12976012
    [No Abstract]   [Full Text] [Related]  

  • 38. Multiple myeloma. III. Effect of urethane therapy on plasma cell growth, abnormal serum protein components and Bence Jones proteinuria.
    RUNDLES RW; DILLON ML; DILLON ES
    J Clin Invest; 1950 Sep; 29(9):1243-60. PubMed ID: 14774471
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of malignant systemic diseases].
    VIDEBAEK A
    Nord Med; 1956 Mar; 55(10):320-3. PubMed ID: 13309805
    [No Abstract]   [Full Text] [Related]  

  • 40. Fatal duodenal perforation during prednisone therapy.
    KELLOCK IA; SCLARE G
    Br Med J; 1957 Apr; 1(5024):930-1. PubMed ID: 13413256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.